1.
Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population
by Schuur, M
Journal of neurology, neurosurgery and psychiatry, 2011-01, Vol.82 (1), p.41-4

2.
Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol
by Schmidt, Ellen M
American journal of human genetics, 2014-02-06, Vol.94 (2), p.233-245

3.
PET Imaging of Tau Deposition in the Aging Human Brain
by Schöll, Michael
Neuron (Cambridge, Mass.), 2016-03-02, Vol.89 (5), p.971-982

4.
Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population
by Licher, Silvan
Nature medicine, 2019-09, Vol.25 (9), p.1364-1369

5.
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
by Cruchaga, Carlos
Neuron (Cambridge, Mass.), 2013-04-24, Vol.78 (2), p.256-268

6.
Estrogen use and early onset Alzheimer's disease: a population-based study
by Slooter, Arjen J C
Journal of neurology, neurosurgery and psychiatry, 1999-12, Vol.67 (6), p.779-297

7.
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis
by Rannikmäe, Kristiina
Journal of neurology, neurosurgery and psychiatry, 2014-03, Vol.85 (3), p.300-305

8.
Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases
by Kovacs, Gabor G
Journal of neuropathology and experimental neurology, 2017-04-01, Vol.76 (4), p.270-288

9.
Prevalence of Apolipoprotein E4 Genotype and Homozygotes (APOE e4/4) among Patients Diagnosed with Alzheimer’s Disease: A Systematic Review and Meta-Analysis
by Ward, Alex
Neuroepidemiology, 2012-01, Vol.38 (1), p.1-17

10.
Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study
by Lee, Alexandra K
Diabetologia, 2018-06-30, Vol.61 (9), p.1956-1965

11.
DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease
by Shao, Yvonne
Journal of human genetics, 2018-04, Vol.63 (4), p.459-471

12.
Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis
by Rannikmäe, Kristiina
Journal of neurology, neurosurgery and psychiatry, 2013-08, Vol.84 (8), p.901-908

13.
Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database
by Ringman, John M
Journal of neuropathology and experimental neurology, 2016-03, Vol.75 (3), p.284-290

14.
Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies
by Colom-Cadena, Martí
Journal of neuropathology and experimental neurology, 2013-12, Vol.72 (12), p.1203-1212

15.
Mental and Physical Activities Delay Cognitive Decline in Older Persons with Dementia
by Cheng, Sheung-Tak, Ph.D
The American journal of geriatric psychiatry, 2014, Vol.22 (1), p.63-74

16.
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
by Gold, Michael
Dementia and geriatric cognitive disorders, 2010-09, Vol.30 (2), p.131-146

17.
Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial
by Durga, Jane, Dr
The Lancet (British edition), 2007, Vol.369 (9557), p.208-216

18.
Plasma apolipoprotein A5 and triglycerides in type 2 diabetes
by Dallinga-Thie, G. M
Diabetologia, 2006, Vol.49 (7), p.1505-1511

19.
The Association between Apolipoprotein E and Traumatic Brain Injury Severity and Functional Outcome in a Rehabilitation Sample
by Ponsford, Jennie
Journal of neurotrauma, 2011-09-01, Vol.28 (9), p.1683-1692

20.
Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss
by Francis, P J
Journal of medical genetics, 2009-05, Vol.46 (5), p.300-307
